Trumpas laikotarpisVidutinis laikotarpisIlgas laikotarpisSignalai

Esperion Therapeutics Inc [ESPR]

Birža: NASDAQ
Sektorius: Healthcare
Pramonė: Biotechnology
Paskutinį kartą atnaujinta 20 Jun 2026 @ 10:31 (Exchange is closed for the weekend)
Paskutinė: $0 0.00%
1.63 (↓)
GaG Algo Score™
v1.0
Trumpas
1.63 (↓)
Vidutinis
2.79 (↓)
Ilgas
2.08 (↓)
PIRKTI
57.14%
grąža 4.06%
PARDUOTI
40.00%
grąža -1.99%

Statistika

Šiandienos apimtis 0
Vidutinė apimtis 0
Rinkos kapitalizacija 654.91M
EPS $-0.100 (Q1 | 2026-05-08)
Kita rezultatų data ($-0.0200) 2026-08-04
ATR14 $0.0180 (0.57%)
Galimas dienos svyravimas $3.14 - $3.16 (0.57%)

Palaikymo ir pasipriešinimo lygiai

Linija

Pivot duomenys

Pivot statistika
Nepakanka pivot duomenų statistikai.
Kito pivot prognozė Paskutinė: $0.00
Pagal turimus duomenis prognozės sukurti nepavyko.

Modest drop for Esperion Therapeutics Inc.

Esperion Therapeutics Inc (ESPR) stock price declined on Thursday after the stock fell $-0.0200 (-0.63%) from the previous session on very high volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 1.91% rise. With 17.50M shares traded, volume yesterday reached $55.12M. This was 1.34M shares more than the prior day. Compared to the 10-day average of 9.68M shares, volume was more than the average.

Esperion Therapeutics Inc signals

The last moves is moving the stock closer to overbought levels, which may signal growing momentum but also increasing risk of a pullback. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (23.3%), medium- (23.3%), and long-term (23.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Esperion Therapeutics Inc Support & Resistance Levels

The stock is trading above the closest support level at $3.13. approximately $0.0200 (0.63%) away. This suggests it is currently acting as a floor, consolidating near support.The sup dis das support s13.13 -

Esperion Therapeutics Inc Evaluation

  • Trumpas balas: 1.63
  • Vidutinis balas: 2.79
  • Ilgas balas: 2.08